Medical disclaimer
This article is for general education and is not medical advice. It is not a substitute for evaluation, diagnosis, or treatment by a licensed clinician. Talk with a qualified clinician about your individual situation.
Compounded medications
Harbor is a technology platform. Medical evaluations are conducted by independent, licensed healthcare providers who determine whether treatment is appropriate. Providers may prescribe FDA-approved or compounded medications based on clinical judgment and patient needs. Compounded medications are not FDA approved and are not reviewed by the FDA for safety or effectiveness.
Sources
- Federal Register. Determination that GEREF (sermorelin acetate) injection was not withdrawn from sale for reasons of safety or effectiveness. 78 FR 14095 (March 4, 2013).
- U.S. Food and Drug Administration. Drugs@FDA: GEREF, NDA 020443.
- U.S. Food and Drug Administration. Compounding and the FDA: questions and answers (content current as of September 16, 2025).
- U.S. Food and Drug Administration. FD&C Act provisions that apply to human drug compounding.
- U.S. Food and Drug Administration. Questions and answers on dietary supplements (content current as of August 27, 2026).
- U.S. Food and Drug Administration. Bulk drug substances used in compounding under section 503A of the FD&C Act (categories updated May 14, 2026).
- DailyMed. Genotropin (somatropin) for injection, prescribing information (revised July 2026).
- 21 U.S.C. 333(e). Prohibited distribution of human growth hormone. Legal Information Institute, Cornell Law School.
- Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-157.
- Walker RF. Sermorelin: a better approach to management of adult-onset growth hormone insufficiency? Clin Interv Aging. 2006;1(4):307-308.
- Corpas E, et al. Growth hormone (GH)-releasing hormone-(1-29) twice daily reverses the decreased GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab. 1992;75(2):530-535.
- Vittone J, et al. Effects of single nightly injections of growth hormone-releasing hormone (GHRH 1-29) in healthy elderly men. Metabolism. 1997;46(1):89-96.
- Tam CS, et al. Increased human growth hormone after oral consumption of an amino acid supplement: results of a randomized, placebo-controlled, double-blind, crossover study in healthy subjects. Am J Ther. 2020;27(4).
- Chromiak JA, Antonio J. Use of amino acids as growth hormone-releasing agents by athletes. Nutrition. 2002;18(7-8):657-661.








